𝔖 Bobbio Scriptorium
✦   LIBER   ✦

High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy

✍ Scribed by Dr. Albert Tran; Jean François Quaranta; Sylvia Benzaken; Valerie Thiers; Hoang Trong Chau; Patrick Hastier; Daniel Regnier; Gilles Dreyfus; Christian Pradier; Jean-Louis Sadoul; Xavier Hebutern; Patrick Rampa

Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
559 KB
Volume
18
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prospective study of interferon therapy
Prospective study of interferon therapy for compensated cirrhotic patients with chronic hepatitis C by monitoring serum hepatitis C RNA
✍ Yasushi Shiratori; Osamu Yokosuka; Ryo Nakata; Masashi Ihori; Katsutaro Hirota; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 2 views

Because interferon therapy exhibits low efficacy for cirrhotic patients infected with hepatitis C virus, this prospective study was conducted to determine effective interferon regimens tailored to treatment response by monitoring HCV RNA status. A total of 157 cirrhotic patients were enrolled to rec

A prospective controlled study of interf
A prospective controlled study of interferon-based therapy of chronic hepatitis C in patients on methadone maintenance
✍ Stefan Mauss; Florian Berger; Joerg Goelz; Bernhard Jacob; Günther Schmutz 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB 👁 2 views

We examined the feasibility of hepatitis C treatment in patients on opioid maintenance. One hundred patients with chronic hepatitis C, 50 on methadone maintenance, and 50 with no intravenous drug use or opioid maintenance for at least 5 years were prospectively matched for sex, age, hepatitis C viru

High prevalence of serological markers o
High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C
✍ Bernard D. Clifford; Daniel Donahue; Lynda Smith; Edward Cable; Brigit Luttig; M 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 851 KB

The advent of specific antiviral therapy for chronic hepatitis C has increased the importance of establishing the correct etiology of chronic hepatitis in patients, especially because interferon alfa (IFN-a) has been reported to exacerbate autoimmune hepatitis (AIH), whereas corticosteroids increase

Efficacy and safety of interferon alfa t
Efficacy and safety of interferon alfa therapy in chronic hepatitis C with autoantibodies to liver-kidney microsomes
✍ Luca Todros; Giorgio Saracco; Marilena Durazzo; Maria Lorena Abate; Giovanni Tou 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 521 KB

Interferon alfa (IFN) therapy is efficacious in chronic viral hepatitides. It may, however, cause adverse immunologic reactions in patients with concomitant autoimmune phenomena. A minority of patients with chronic type C hepatitis have antibodies against liver and kidney microsomes (anti-LKM) in se

A randomized controlled trial of high-do
A randomized controlled trial of high-dose maintenance interferon therapy in chronic hepatitis C
✍ Di Marco, Vito; Lo Iacono, Oreste; Cammà, Calogero; Almasio, Piero L.; Vaccaro, 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 2 views

In chronic hepatitis C virus (HCV) infection, the rate of sustained response to interferon is low. We evaluated, in patients responding to a 26-week course of interferon, the effect of high-dose maintenance therapy in preventing relapse. Three hundred and ten patients with chronic HCV infection (38.

Prevalence and impact of occult hepatiti
Prevalence and impact of occult hepatitis B infection in chronic hepatitis C patients treated with pegylated interferon and ribavirin
✍ Marion Levast; Sylvie Larrat; Marie-Ange Thelu; Sandrine Nicod; Agnès Plages; Al 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 2 views

## Abstract The prevalence of occult hepatitis B, defined by absence of HBsAg and HBV DNA, ranges widely in patients with hepatitis C. This may influence the treatment of hepatitis C and the severity of liver disease. Sensitive and specific real‐time PCR techniques are available commercially and ca